Day: May 18, 2026

SGX corporate News

mDR Limited Announces Allotment and Listing Dates for Rights Shares and Warrants on SGX-ST (May 2026)

Minichart

May 18, 2026

mDR Limited Announces Successful Allotment and Listing of Ri...

Continue Reading 0

SGX corporate News

UHREIT 1Q 2026 Results: Strong Financial & Operational Performance, Resilient U.S. Grocery-Anchored Portfolio, and Attractive Dividend Yield

Minichart

May 18, 2026

UHREIT 1Q 2026 Financial and Operational Performance Report ...

Continue Reading 0

SGX corporate News

Serial System Ltd 2026 AGM Highlights: Financial Performance, Business Outlook, and Shareholder Resolutions

Minichart

May 18, 2026

Serial System Ltd FY2025 AGM Detailed Report: Key Insights f...

Continue Reading 0

SGX corporate News

Coliwoo Holdings 1HFY2026 Business Updates: Financial Highlights, Growth Strategies, and Singapore Co-Living Expansion

Minichart

May 18, 2026

Coliwoo Holdings 1HFY2026 Business Update: Key Highlights fo...

Continue Reading 0

SGX corporate News

Frencken Group 1Q26 Business Update: Revenue, Outlook, and Growth Strategies for FY2026

Minichart

May 18, 2026

Frencken Group Limited 1Q26 Business Update: Key Points for ...

Continue Reading 0

SGX corporate News

MetaOptics Ltd Files Amended Registration Statement for Proposed Dual Listing on Nasdaq – Latest Update 2026

Minichart

May 18, 2026

MetaOptics Ltd: Update on Proposed Dual Nasdaq Listing ...

Continue Reading 0

us corporate news

VPR Brands, LP 2026 Q1 Financial Results and Patent Monetization Strategies – SEC 10-Q Report

Minichart

May 18, 2026

VPR Brands, LP - Q1 2026 Financial Report: Investor Highligh...

Continue Reading 0

us corporate news

iSpecimen Inc. Q1 2026 10-Q Report: Financial Performance, Going Concern, and Reverse Stock Split Overview

Minichart

May 18, 2026

iSpecimen Inc. Q1 2026 Financial Report - Investor Analysis ...

Continue Reading 0

us corporate news

Estrella Immunopharma, Inc. 2026 Q1 Financial Report: Key Financials, Related Party Transactions, and R&D Update

Minichart

May 18, 2026

Estrella Immunopharma, Inc. Q1 2026 Financial Report: Key Hi...

Continue Reading 0

us corporate news

OS Therapies Inc. (OSTX) Q1 2026 Quarterly Report: Financials, Subsidiaries, HER2 Asset Acquisition, and Clinical Trial Updates

Minichart

May 18, 2026

OS Therapies Q1 2026 Financial Results: Key Highlights, Risk...

Continue Reading 0